Evidence map›Paper›PMID 22528497›Full record

ArticleThe Journal of biological chemistry2012

Global analysis of the regulon of the transcriptional repressor LexA, a key component of SOS response in Mycobacterium tuberculosis.

Katherine L Smollett, Kimberley M Smith, Christina Kahramanoglou, Kristine B Arnvig, Roger S Buxton, Elaine O Davis

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Calprotectin protectsmSystems · 2025
    Article
  3. Article
  4. Transcriptomic responses to antibiotic exposure inAntimicrobial agents and chemotherapy · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
  17. Review
  18. Morphological profiling of tubercle bacilli identifies drug pathways of action.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Katherine L SmollettDivision of Mycobacterial Research, Medical Research Council National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom. k.smollett@ucl.ac.uk
Kimberley M Smith
Christina Kahramanoglou
Kristine B Arnvig
Roger S Buxton
Elaine O Davis
The Francis Crick Institute · GB

Funding

Medical Research Council MC_U117585867Medical Research Council U1175 32056Medical Research Council U117581288Medical Research Council U117585867
6 · The paper itself

Abstract

The DNA damage response is crucial for bacterial survival. The transcriptional repressor LexA is a key component of the SOS response, the main mechanism for the regulation of DNA repair genes in many bacteria. In contrast, in mycobacteria gene induction by DNA damage is carried out by two mechanisms; a relatively small number of genes are thought to be regulated by LexA, and a larger number by an alternate, independent mechanism. In this study we have used ChIP-seq analysis to identify 25 in vivo LexA-binding sites, including nine regulating genes not previously known to be part of this regulon. Some of these binding sites were found to be internal to the predicted open reading frame of the gene they are thought to regulate; experimental analysis has confirmed that these LexA-binding sites regulate the expression of the expected genes, and transcriptional start site analysis has found that their apparent relative location is due to misannotation of these genes. We have also identified novel binding sites for LexA in the promoters of genes that show no apparent DNA damage induction, show positive regulation by LexA, and those encoding small RNAs.

Indexed as

Gene Expression Regulation, BacterialAmino Acid SequenceBacterial ProteinsBinding SitesCell-Free SystemChromatin ImmunoprecipitationDNA DamageEscherichia coliLexA Repressor ProteinMolecular Sequence DataMycobacterium tuberculosisPlasmidsPromoter Regions, GeneticProtein BindingRecombinant ProteinsRNABacterial ProteinsLexA Repressor ProteinRecombinant ProteinsRNASerine Endopeptidases

Identifiers

PMID22528497
PMCPMC3381160
OpenAlexW2038498901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.